Guest Post: GeoInvesting on KEQU Panic Selling Amid NIH Budget Cuts

Another guest post focusing on a MSMqi stock…

Let’s take a dive into if KEQU’s pullback of 43.7% from its highs on National Institutes of Health (NIH) funding budget cut fears from the new administration. We have the answers on whether it’s overblown or if investors should be concerned.